About: http://data.cimple.eu/news-article/3ad027289893aad2fea9a50aafb30d3466ef5d3283bbade7ff6b7f6e

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/3ad027289893aad2fea9a50aafb30d3466ef5d3283bbade7ff6b7f6e Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	British Prime Minister Boris Johnson on Friday received a first dose of AstraZeneca's Covid vaccine, at the London hospital where he fought for his life almost a year ago, assuring the public the jab is safe. "I literally did not feel a thing. It was very good, very quick," the 56-year-old leader told reporters at St Thomas' Hospital in central London, close to his Downing Street residence. "Everybody, when you do get your notification to go for a jab, please go and get it," Johnson said. "It's the best thing for you, the best thing for your family and for everybody else," he added, stressing the renewed green light given by scientists in Europe for the AstraZeneca jab.. "The risk is Covid. This is a great thing to do," Johnson said, hours after French Prime Minister Jean Castex received the AstraZeneca injection live on television. Johnson spent a week at St Thomas' Hospital, including three days in intensive care, after he was diagnosed with the coronavirus at the end of March last year. He said after coming out that his personal battle with the coronavirus "could have gone either way", and there was "no question" doctors saved his life. AstraZeneca's jab, developed with Oxford University, provides the bulk of Britain's inoculation campaign and a large portion of its supply has been produced by the Serum Institute of India, the world's biggest vaccine maker. The institute this week said it could not provide planned deliveries next month, denting Britain's otherwise impressive campaign, which has delivered more than 26 million first doses. The supply issues are another headache for AstraZeneca after its jab was suspended in several EU countries, pending a review by the European Medicines Agency following isolated cases of blood clots and brain haemorrhages. The EMA restated its approval for the vaccine on Thursday, as did Britain's own drugs regulator. jit/pvh
schema:headline	UK PM receives first dose of AstraZeneca vaccine
schema:mentions	St Thomas' Hospital Downing Street Brain tumor Everybody (Madonna song) Headache European Medicines Agency Intensive care unit Thrombus Jab University of Oxford Prime Minister of the United Kingdom Boris Johnson AstraZeneca London European Union India Coronavirus disease United Kingdom Vaccine Coronavirus disease 2019 Ouvrage Denting Royal London Hospital PVH (company)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-19 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	77 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software